Core Insights - Sanofi, a French pharmaceutical giant, has signed a strategic cooperation agreement with Moroccan biotechnology company Marbio to jointly produce various vaccines [1] Group 1: Vaccine Production - The agreement includes the joint production of a six-in-one vaccine for newborns, which covers diphtheria, tetanus, whooping cough, polio, hepatitis B, and Haemophilus influenzae type b [1] - Other vaccines planned for production include those for meningitis, rabies, influenza, and yellow fever, indicating a broad scope of infectious disease prevention [1] Group 2: Regional Health Development - This collaboration marks a significant step for Morocco in strengthening its vaccine industry chain and enhancing regional health autonomy [1]